A review of the U.S. Federal Trade Commission (FTC) method for determining tar, nicotine and carbon monoxide levels in U.S. cigarettes by the National Cancer Institute, with contributions from an expert panel of medical, legal and tobacco industry personnel. Focuses on the health effects of the components of cigarette smoke with discussions on consumer smoking patterns and perceptions of FTC labeling of tar and nicotine ratings. Examines the FTC testing parameters with recommendations for changes to those parameters and to labeling. Tables, graphs and references.

This book presents a counter-view, based on a survey of several thousand young persons and adults, probing attitudes, beliefs, feelings, and perceptions of risk associated with smoking. The authors agree that young smokers give little or no thought to health risks or the problems of addiction. The survey data contradicts the model of informed, rational choice and underscores the need for aggressive policies to counter tobacco firms' marketing and promotional efforts and to restrict youth access to tobacco.

"Summaries of papers" contained in the journal accompany each issue, 19--

This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.

Despite overwhelming evidence of tobacco's harmful effects and pressure from anti-smoking advocates, current surveys show that about one-quarter of all adults in the United States are smokers. This audience is the target for a wave of tobacco products and pharmaceuticals that claim to preserve tobacco pleasure while reducing its toxic effects. Clearing the Smoke addresses the problems in evaluating whether such products actually do reduce the health risks of tobacco use. Within the context of regulating such products, the committee explores key questions: Does the use of such products decrease exposure to harmful substances in tobacco? Is decreased exposure associated with decreased harm to health? Are there surrogate indicators of harm that could be measured quickly enough for regulation of these products? What are the public health implications? This book looks at the types of products that could reduce harm and reviews the available evidence for their impact on various forms of cancer and other major ailments. It also recommends approaches to governing these products and tracking their public health effects. With an attitude of healthy skepticism, Clearing the Smoke will be important to health policy makers, public health officials, medical practitioners, manufacturers and marketers of "reduced-harm" tobacco products, and anyone trying to sort through product claims.